Author Guidelines

Submission checklist

Please:

  1. Read the Aims & Scope to gain an overview and assess if your manuscript is suitable for this journal;
  2. Use the Microsoft Word template to prepare your manuscript;
  3. Make sure that issues about publication ethics, plagiarism policy, copyright, peer review process, and declaration form have been appropriately considered;
  4. Ensure that all authors have approved the content of the submitted manuscript.

Peer-review process

In the review process, IJABSA involves writers, editors, section editors, and reviewers. Where in the review process, this Journal applies the Double-Blind Review model to maintain confidentiality. The editor first checks every script that is submitted, if the article meets the focus and scope and guidelines for writing this Journal, the manuscript is continued to the reviewer to review the content and novelty of the paper, if not then the article will be returned to the author. A minimum of two reviewers will examine each paper for six weeks with the criteria for evaluating the manuscript, as stated in the Article Rating Form for Reviewers.

Submission process

Manuscript submission to the IJABSA is only possible through the Journal’s Online Paper Submission page.

Manuscript must be accompanied by a covering letter to the Editor-in-Chief, including title and author(s) name and undertaking that it has not been published or submitted elsewhere. In case the manuscript was earlier submitted to some other journals and was rejected, the authors must provide full information for proper analysis. 

Title page and manuscript text files should be separately submitted online via the Online Paper Submission system

Manuscript preparation

1-Summary

Title page, Including title of article, author’s names , affiliations, and detail information of corresponding authors; Phone, Fax number, Email, and Postal Address should be supplied and submitted as a separate file. Manuscript text file should be prepared according to specific research reporting guidelines (See table). In addition, Appendix section including acknowledgment, funding, and author’s contribution should be addressed at the end of the manuscript text in all types of above mentioned studies. All clinical trials should be registered in a registry of clinical trials proposed by the World Health Organization (WHO) or the International Committee of Medical Journal Editors (ICMJE). 

Standard Reporting Guidelines

Type of study

Guideline

Clinical Trials

CONSORT

Observational

STROBE

Systematic reviews and meta-analysis on clinical trials       

PRISMA

Meta-analysis of observational studies

MOOSE

Diagnostic accuracy

STARD

Qualitative research

COREQ

Others

See here…

1-Details

The journal adheres to the conditions stated by the International Committee of Medical Journal Editors (ICMJE). The main manuscript should carry the title, abstract, main text, acknowledgment, funding, author’s contribution, references, figures, and tables of the paper. The preferred word processing format for the manuscript file is Microsoft Word version 2003 or newer. Manuscripts should be double-spaced, with 2.5 cm margins on all sides. All abbreviations must be spelled out the first time used, followed by the abbreviated form in parentheses. Units of measurement must be complied with the International System of Units (SI). For indexing, three to five key words should be typed at the end of the abstract for each manuscript. These words should be identical to the medical subject headings (MeSH) that appear in the Index Medicus of the National Library of Medicine.

Observational Studies (Original Articles)

Cohort, case control, and cross-sectional studies should be arranged based on Strengthening the Reporting of Observational studies in Epidemiology (STORBE) statement and checklist as: Abstract, Keywords, Introduction, Methods, Results, Discussion, Conclusion, Acknowledgements, References, Tables, and Figures. A structured abstract (with the subheadings title, introduction, methods, results, and conclusion) should appear on the first page of the manuscript and should not exceed 350 words. The main text (excluding the abstract and references) should not exceed 4500 words.

Clinical Trials

Original research papers that report a randomized controlled trial, should comply with the guidelines provided by the Consolidated Standards of Reporting Trials (CONSORT) group. Also, supplying the manuscript with a CONSORT flowchart diagram is highly encouraged. Researchers who would like to publish their clinical trial reports in Emergency are strongly encouraged to register their studies in a registry of clinical trials proposed by the World Health Organization (WHO) or the International Committee of Medical Journal Editors (ICMJE). As an option, the Iranian Registry of Clinical Trials (IRCT) is a registry suggested by WHO.

Review Articles and Systematic Review Articles

Should be requested by the editor, but IJABSA will also accept submitted reviews. The authors of review articles are invited to contact the Editorial Office before preparing a review article. Review articles should be composed of systematic critical assessments of literature and data sources pertaining to clinical topics, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention. They should have unstructured abstracts. All articles and data sources should include information about the specific types of study or analysis, population, intervention, exposure, and tests or outcomes. Authors of review articles should be expert and have contributions in the field of the addressed subject. Systematic reviews and meta-analyses on clinical trials and observational studies should be prepared based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analysis of observational studies in epidemiology (MOOSE), respectively. This type of articles should be limited to 5000 words.

Case Reports

Case reports should be arranged as follows: Abstract (Structured: background, case report, conclusion, not exceeding 200 words), Introduction, Case Report, Discussion, Conclusion, References, and 1 to 4 Figures. Necessary documentations of the case(s) like pathology and laboratory test reports should be included in the submission package. The length should not exceed 2000 words.

Short Communications

Original research papers can also be published in a Short Communications. Submitted papers that are of interest but not acceptable as a full-length original contribution, are offered by the editor to be published in this section. Also, the authors can primarily submit their papers for consideration of publication in this section. An unstructured abstract no longer than 150 words is required for this section. The body of the manuscript should not exceed 1500 words, and no heading or subheading should be used. Tables and/or figures should be limited to 2 ones and references to 15 in maximum.

Letters to the Editor

All correspondence will be considered for publication if it contains constructive criticism on previously published articles in IJABSA during the previous six months, the authors of which will have the right of reply. Also, reports of limited research or clinical experiences can be submitted in the form of a letter. The length should not exceed 700 words. Letters will undergo peer-review processing and will be edited for clarity.

Appendix:

Conflict of Interest

Authors are expected to disclose any commercial associations or sources of support that might pose a conflict of interest in connection with the submitted article. All funding sources supporting the work must be declared in appendix section at the end of manuscript. Whole affiliations with or financial involvement in any organization on entity with a direct financial interest in the subject matters or materials of the research discussed (examples: employment, consultancies, stock ownership or other equity interest, patent-licensing arrangements) should be cited as conflict of interest at the end of manuscript text file.

Authorship

Based on the ICJME recommendations "all those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged".

References:

Our reference style requirements are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals by the Vancouver style. You may find a complete guideline on Vancouver reference style here.

Figures and tables:

Figures and tables should be kept to a minimum necessary and their information should not be duplicated in the text. Tables and figures should be typed on separate sheets of the manuscript file, numbered, and have a title. Include double-spaced legends (maximum length, 60 words) on separate pages.

Tables as well as illustrations should be typed and drawn at the end of the manuscript after the references. Do not submit tables as photographs.

The figures should be sent in a format of JPEG or GIF which will produce high quality images in the online edition of the journal.

Responsibility and ethical requirements:

Author(s) should certify that neither the submitted manuscript nor other one with substantially similar content under their authorship has been published in any language or being considered for publication elsewhere. Author(s) takes responsibility for the integrity of the work as a whole, from inception to published article. In the event that an author is added or removed from the list of authors, written acceptance, signed by author(s), must be submitted to the editorial office. Sources of financial support of the project should be acknowledged. If the study involves human beings, the author(s) must include a statement that the study was approved by the local ethical committee and that written informed consent was obtained from the study participants. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. Also, the maintenance and care of experimental animals complies with National Institutes of Health guidelines for the human use of laboratory animals, should be declared in text. All relevant permissions to cite the unpublished observations of others must be obtained by the manuscript author(s). The names and initials of these persons must be cited in the text, and permission from the original author(s) obtained. Also, permission must be obtained to reproduce or adapt any figures or tables that have been published previously. The Emergency conforms to the international regulations against scientific misconduct including fabrication, falsification, plagiarism, and etc. Any cases of suspected misconduct will be assessed during the peer-review and publication process based on the guidelines of the Committee on Publication Ethics (COPE).

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.